­

News: BioMarin reports cancer case in hemophilia gene therapy trial

­

Drug regulators have not ordered a trial hold after an analysis suggested leukemia was naturally occurring, company says. BioMarin Pharmaceutical, a California-based biotechnology company, said a patient in a clinical trial of its hemophilia gene therapy Roctavian has developed leukemia, although testing suggests that the case may be naturally occurring.

Read more…

­

­

Conference: iPSC-Derived Immunotherapies Congress

­

Running in Boston from October 18-19, the iPSC-Derived Immunotherapies Congress is your opportunity to analyze developments in bringing iPSC-Derived immunotherapies from bench to bedside to deliver long-lasting, safe and effective therapeutics.

iPSCs show great promise in addressing the current challenges surrounding cost and demand associated with current cell therapies on the market, but with genomic stability concerns and manufacturing complexities, these therapies are still at early stages of clinical progression.

Past attendees to the cell therapy congress series include Novartis, Allogene Therapeutics and Kite Pharma – and with a range of experts in the field confirmed to speak at the congress in October, it is promised to be just as valuable.
Register now…

­

­

Conference: Neoantigen-Based Therapies Summit

­

Returning for the 7th year, the Neoantigen-Based Therapies Summit remains your comprehensive guide to transforming the clinical development of cell and vaccine based neoantigen therapies.
Join us in Boston (October 24-26) to connect with the pioneers of the neoantigen field setting a trailblazing fire to the immunotherapy industry as they gather in-person to discuss what the optimal control, clinical and combination trial designs should look like, and explore how we can manufacture effectively and scale both shared and personalized neoantigen based therapies.
Register now…

­

­

Conference: Onco Cell Therapy Summit: Europe 

­

The Onco Cell Therapy Summit: Europe is the perfect opportunity to meet with Europe’s leading innovators and investors, driving partnerships, collaboration and adoptive cell therapies to the market.

Running from November 2-3 in Amsterdam at the Amsterdam Marriott Hotel, it is the only event in mainland Europe bringing together industry giants to cover the whole range of autologous and allogeneic cell therapy advancements.

Over the two day summit, you can expect to hear from more than 45 industry experts including AstraZeneca, Novartis, Autolus and many more companies will be in attendance, making the networking opportunities a must. 

Register now…

­

­

Conference: Oxford Global’s 8th Annual Cell & Gene Therapy Manufacturing Congress

­

Join Oxford Global’s 8th Annual Cell & Gene Therapy Manufacturing Congress, 7 - 8 November 2022 in London, UK. Be part of our key forum to solve production challenges and overcome manufacturing bottlenecks in cell and gene therapy manufacturing. Case studies provide key insight into inherent challenges, including scale-up, regulation and automation.

Register now…

­

­

Conference: Emerging Non-Coding RNA Therapeutics Summit

­

As the RNA revolution continues off the back of the COVID-19 pandemic, biopharma and investors are now turning their attention to emerging non-coding RNA therapies beyond just mRNA.

That’s why we are excited to bring the eagerly anticipated Emerging Non-Coding RNA Therapeutics Summit to the field on November 8-10, 2022.

Get your exclusive copy of the official Event Guide here.

This is the only industry-dedicated summit dedicated to advancing the targeting of non-coding RNAs, such as long non-coding RNAs and microRNAs, by enhancing target selectivity to expand druggability across different indications and optimizing delivery, formulation and PKPD
Register now…

­

­

Conference: 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit

­

The gene and cell therapies clinical impact, production and processes efficiency hardly depend on the unique challenges, related to CMC, analytical, process development, automation, manufacturing, facility design, aseptic processing, supply chain and other, developers of gene and cell therapies must resolve. Join the leading practitioners and consultants at the 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit, 16-17 November 2022, Vienna, Austria.

Register now…

­

­

Conference: 6th Aseptic Processing Summit

­

Join the leading practitioners and consultants at the 6th Aseptic Processing Summit, 17-18 November 2022, Vienna, Austria.

Register now…

­

­

Upcoming conferences and meetings

­

• 19 - 23 September 2022 - 7th Annual CAR-TCR Summit - Boston, MA
• 20 - 21 September 2022 - Cell & Gene Therapy USA 2022 - Online event
• 20 - 22 September 2022 - mRNA Process Development & Manufacturing Summit - Boston, MA
• 21 - 22 September 2022 - Oligonucleotide Therapeutics and Delivery 2022 - London, UK
• 26 - 28 September 2022 - International Human Gene Therapy Conference - Melbourne, Australia
• 27 - 30 September 2022 - Cell & Gene Therapy Manufacturing & Commercialization US - Boston, MA & Online
• 4 – 6 October 2022 - 4th Exosome Based Therapeutic Development Summit: Gene delivery therapies - Boston, MA
• 11 – 14 October 2022 - XXIX Congress of the European Society of Gene and Cell Therapy (ESGCT) - Edinburgh, UK
• 13 - 14 October 2022 - Global Bioprocessing Summit and Expo - ATMP Development - Berlin, Germany
• 18 - 19 October 2022 - iPSC-Derived Immunotherapies Congress - Boston, MA
• 18 - 20 October 2022 - 3rd Annual Gene Therapy Immunogenicity Summit - Boston, MA
• 18 - 20 October 2022 - Process Development for Cell Therapies Summit - Boston, MA
• 18 - 20 October 2022 - Innate Killer Summit Europe - London, UK
• 20 - 21 October 2022 - Reuters Events: Oncology at Total Health 2022 - T-cell therapies - Chicago, USA
• 24 - 26 October 2022 - 4th TIL Therapies Summit - Boston, MA
• 24 - 26 October 2022 - 7th annual Neoantigen-Based Therapies Summit 2022 - Boston, MA
• 25 - 27 October 2022 - 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022 - London, UK
• 27 - 28 October 2022 - Medical Affairs Summit - Cell and Gene Therapies - Boston, MA
• 2 – 3 November 2022 - Onco Cell Therapy Summit 2022 - Amsterdam, The Netherlands
• 7 – 8 November 2022 - 8th Annual Cell & Gene Therapy Manufacturing Congress - London, UK
• 8 – 10 November 2022 - Emerging Non-Coding RNA Therapeutics Summit - Boston, MA
• 16 – 17 November 2022 - 3rd Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit - Vienna & Online
• 16 – 18 November 2022 - Joint meeting of the Australasian Gene and Cell Therapy Society - Melbourne, Australia
• 17 – 18 November 2022 - 6th Aseptic Processing Summit - Manufacturing ATMPs and vaccines - Vienna & Online
• 28 - 30 November 2022 - 2nd Rare CNS & Neurodevelopmental Drug Development Summit - Boston, MA
• 28 November - 1 December 2022 - 4th Annual Gene Therapy Analytical Development - Boston, MA
• 5 - 7 December 2022 - Cell Therapy Analytical Development Summit - Boston, MA
• 5 - 8 December 2022 - Cell & Gene Therapy Manufacturing & Commercialization Europe - Amsterdam & Online
• 5 - 8 December 2022 - 4th Annual Gene Therapy for Neurological Disorders - Boston, MA

­